A case study of a young man with intellectual disability, mitochondrial disorder, epilepsy, autism and psychosis: how did we decide which psychotropic drug to use?

Welcome:
Guest

Advances in Mental Health and Intellectual Disabilities

Online from: 2010

Subject Area: Health and Social Care

Content: Latest Issue | Latest Issue RSS | Previous Issues

Options: To add Favourites and Table of Contents Alerts please take a Emerald profile

Document Information:
Title:	A case study of a young man with intellectual disability, mitochondrial disorder, epilepsy, autism and psychosis: how did we decide which psychotropic drug to use?
Author(s):	Simon Bonell, (South London and Maudsley NHS Foundation Trust, UK), Jane McCarthy, (South London and Maudsley NHS Foundation Trust, UK)
Citation:	Simon Bonell, Jane McCarthy, (2010) "A case study of a young man with intellectual disability, mitochondrial disorder, epilepsy, autism and psychosis: how did we decide which psychotropic drug to use?", Advances in Mental Health and Intellectual Disabilities, Vol. 4 Iss: 3, pp.45 - 48
Keywords:	Autism, Epilepsy, Intellectual disability, Learning disabilities, Mitochondrial disorder, Psychosis, Psychotropic medication, Side-effects
Article type:	General review
DOI:	10.5042/amhid.2010.0543 (Permanent URL)
Publisher:	Emerald Group Publishing Limited
Abstract:	This case report highlights the complex factors in prescribing psychotropic medication for people with intellectual disability with significant co-morbid physical and mental health problems. The case study is of a young man with a mitochondrial disorder, secondary sensory impairments, mild intellectual disability, epilepsy and autism spectrum disorder who developed a psychotic illness. The report focuses on the use of psychotropic medication in this man and discusses the issues regarding psychotropic medication that need to be considered with service users and their carers.